Justin W. Yorke - Jan 27, 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jan 27, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/18/2025, 05:59 PM
Date Of Original Report
Jan 29, 2025
Previous filing
Sep 18, 2024
Next filing
Sep 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 3.74K Jan 27, 2025 Direct
holding PCSA Common Stock 12.4K Jan 27, 2025 By Directed Trust Company FBO Justin Yorke IRA
holding PCSA Common Stock 31.2K Jan 27, 2025 By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +12.4K $0.00 12.4K Jan 29, 2025 Common Stock 12.4K $0.65 By Directed Trust Company FBO Justin Yorke IRA
transaction PCSA Warrants Award $0 +6.2K $0.00 6.2K Jan 29, 2025 Common Stock 6.2K $0.65 By Directed Trust Company FBO Justin Yorke IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.